![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 29, 21928-21938, July 21, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
, and
**
From the
Department of Biochemistry, Imperial College
of Science, Technology, and Medicine,
London SW7 2AY, United Kingdom and the § Department of
Physiological Sciences, Eastern Virginia Medical School,
Norfolk, Virginia 23501
Received for publication, February 23, 2000, and in revised form, April 17, 2000
| |
ABSTRACT |
|---|
|
|
|---|
Tamm-Horsfall glycoprotein (THP) is a major
glycoprotein associated with human urine that binds pro-inflammatory
cytokines and also inhibits in vitro T cell proliferation
induced by specific antigens. THP derived from human pregnancy urine
(designated uromodulin) has previously been shown to be 13-fold more
effective as an inhibitor of antigen-induced T cell proliferation than
THP obtained from other sources. Structural analysis of human THP and
uromodulin has for the first time revealed that these glycoproteins are
O-glycosylated. THP from nonpregnant females and males
expresses primarily core 1 type O-glycans terminated with
either sialic acid or fucose but not the sialyl Lewisx
epitope. By contrast, the O-glycans linked to uromodulin
include unusual core 2 type glycans terminated with one, two, or three sialyl Lewisx sequences. The specific association of these
unusual carbohydrate sequences with uromodulin could explain its
enhanced immunomodulatory effects compared with THP obtained from males
and nonpregnant females. Analysis of THP from one of the pregnant
females 2 months postpartum showed a reversion of the
O-glycan profile to that found for a non-pregnant female.
These data suggest that the glycosylation state of uromodulin could be
under the regulation of steroidal hormones produced during pregnancy.
The significant physiological implications of these observations are discussed.
Tamm-Horsfall glycoprotein
(THP)1 is the most abundant
glycoprotein in human urine (1, 2). The precise physiological role of
THP remains enigmatic, despite considerable investigation of this
glycoprotein over the past 50 years. THP was shown to block
hemagglutination induced by influenza, mumps, and Newcastle disease
viruses (1, 2). THP has been postulated to be essential for protecting
the kidneys from bacterial infections (3, 4). THP has also been
implicated as a potential component necessary for maintenance of the
electrolyte balance in the nephron (5). In addition, THP may also play
a significant role in several pathological conditions involving the
kidney, including acute renal failure, urinary tract infection, stone
formation, and interstitial nephritis (6).
In 1973, two studies (7, 8) suggested that human chorionic gonadotropin
isolated from pregnancy urine suppressed specific immune activities
in vitro. However, this immunosuppressive activity turned
out to be due to a contaminant of the human chorionic gonadotropin preparation (9, 10). Muchmore and Decker (11) later used lectin
affinity chromatography, gel separation, and isoelectric focusing to
purify a glycoprotein from human pregnancy urine that mediated this
immunosuppressive activity. They designated this glycoprotein
"uromodulin" to account for its origin and its immunomodulatory activities. Amino acid sequence analysis (12, 13) revealed that
uromodulin represented THP glycoforms produced during pregnancy.
Uromodulin was initially shown to inhibit antigen-induced T cell
proliferation at relatively low concentrations (11). Subsequent investigations by Muchmore and colleagues (14-16) indicated that uromodulin could also bind to recombinant interleukin-1 and recombinant interleukin-2 and recombinant tumor necrosis factor via its
oligosaccharide sequences. The glycans associated with uromodulin have
been proposed to be essential for its immunosuppressive and cytokine
binding activities (12, 14-16). By contrast, another study indicated that both THP and uromodulin would bind to IL-1 and tumor necrosis factor but only after these cytokines were either denatured or immobilized on solid surfaces (17). However, a more recent study indicates that oligosaccharides associated with THP block IL-1 binding
to immune effector cells and to an IL-1-dependent cell line
(18). The investigators in this study (18) also provided strong
evidence that N-linked glycans terminated with GalNAc, and a
sulfate group mediates these immunomodulatory activities in
vitro. This demonstration that THP or its derivative
oligosaccharides can also mediate cytokine bindings, and specific
responses in immune cells suggests that this glycoprotein is
functionally equivalent to uromodulin. However, Muchmore and co-workers
(12) suggested that uromodulin was a 13-fold more active inhibitor of
antigen-specific T cell proliferation than THP. The observation that
THP and uromodulin express identical polypeptide sequences suggests
that pregnancy-related changes in post-translational modifications
could be responsible for their differential immunosuppressive activities.
The present investigation was undertaken to determine if THP and
uromodulin are differentially glycosylated. Several pregnancy associated changes in the glycosylation of THP were found, the most
notable being that uromodulin specifically expresses unusual core 2 type O-linked glycans terminated with up to three sialyl Lewisx sequences.
Purification of THP/Uromodulin--
THP or uromodulin was
purified from urine from a range of individuals. Each sample was
prepared individually. THP was isolated using the same procedure
originally employed by Tamm and Horsfall (1). The urine sample was
adjusted to pH 7.0 using sodium hydroxide. Sodium chloride was then
added and dissolved to give a final concentration of 0.58 M
NaCl. The sample was then left at 4 °C for 5 h followed by
centrifugation at 1000 rpm for 30 min. The supernatant was removed and
the precipitate resuspended in 2 ml of 0.58 M sodium chloride. The sample was then centrifuged at 4000 rpm for 15 min. The
supernatant was again removed and the precipitate resuspended in 2 ml
of water. This purified THP/uromodulin was then transferred into a
regenerated cellulose dialysis membrane with 12-14-kDa nominal
molecular weight cutoff (Cellu-Sep) and dialyzed against 4 × 2.5 liters of water at 4 °C, the water being changed at 12-h intervals
for 2 days. After dialysis the THP/uromodulin was lyophilized.
Reduction and Carboxymethylation--
THP/uromodulin was subject
to reduction and carboxymethylation of S Tryptic Digestion--
THP/uromodulin was digested with trypsin
using a 1:100 w/w ratio of trypsin (EC 3.4.21.4, Sigma) to
THP/uromodulin as described (19). The incubation period for the
digestion was 5 h. Following termination of the digestion the
sample was lyophilized.
Peptide N-Glycosidase F Digestion--
THP/uromodulin was
digested with 3 units of peptide N-glycosidase F (EC
3.5.1.52, Roche Molecular Biochemicals) as described (19). The reaction
was terminated by lyophilization, and the released N-glycans
were separated from peptides and O-glycopeptides by Sep-Pak
as described (19). Prior to loading onto the conditioned Sep-Pak the
sample was dissolved in 200 µl of 5% acetic acid.
Digestion with Vibrio cholerae Neuraminidase--
Tryptic
O-glycopeptides from uromodulin, present in the 20%
1-propyl alcohol Sep-Pak fraction, were dissolved in 50 mM
ammonium acetate, pH 4.5, and digested with 25 milliunits of V. cholerae neuraminidase (EC 3.2.1.18, Roche Molecular Biochemicals)
for 24 h at 37 °C. Following digestion the sample was lyophilized.
Reductive Elimination--
THP/uromodulin was subject to
reductive elimination as described (19). Following termination of the
reaction using glacial acetic acid, the 20 and 40% 1-propyl alcohol
fractions were combined prior to Dowex chromatography.
Chemical Defucosylation--
The released O-glycans
were dissolved in 50 µl of hydrofluoric acid (Sigma) and placed on
ice for 30 min. The reaction was terminated by drying under a stream of nitrogen.
Periodate Cleavage--
A solution of 2 mM sodium
periodate in 100 mM ammonium acetate, pH 6.5, was prepared,
wrapped in foil, and placed in the fridge for 1 h. Released, dried
O-glycans were then dissolved in 50 µl of this reagent,
wrapped in foil, and placed on ice in the fridge overnight. The
reaction was terminated by the addition of 2 µl of ethylene glycol
and lyophilized. The products of periodate cleavage were reduced using
200 µl of a 10 mg/ml solution of sodium borohydride in 2 M ammonium hydroxide. The reaction was allowed to proceed
at room temperature for 2 h. The reaction was terminated by
addition of glacial acetic acid until all the sodium borohydride had
been neutralized. The sample was subject to Dowex chromatography, borate removal, permethylation, and Sep-Pak clean up using an acetonitrile gradient as described (19).
Chemical Derivatization for FAB-MS and Gas Chromatography-MS
Analysis--
Released glycans were permethylated using the sodium
hydroxide procedure and purified by Sep-Pak using an acetonitrile
gradient as described (19). Partially methylated alditol acetates were prepared from the permethylated glycans as described (20) and analyzed
by gas chromatography-MS.
Mass Spectrometric Analyses--
Fast atom bombardment-mass
spectrometric analysis of permethylated glycans was performed using a
ZAB 2SE 2FPD double-focusing mass spectrometer fitted with a cesium ion
gun operating at 30 kV. The matrix used was monothioglycerol, and all
samples were dissolved in methanol prior to loading. Data were
collected and analyzed using VG Opus® software. Linkage analysis of
partially methylated alditol acetates was carried out using an MD 800 gas chromatography-mass spectrometer. Chromatographic separation was achieved using a 30 m × 0.25 mm inner diameter RTX-5 fused silica capillary column (Restek Corp.). The sample was dissolved in hexanes and injected onto the column at 65 °C. The column was held at this
temperature for 1 min and then increased to 290 °C at a rate of
8 °C per min.
Structural Analysis Strategy--
THP or uromodulin were isolated
as described under "Experimental Procedures" from urine samples of
three males, three non-pregnant females, and two pregnant females.
Additionally THP was isolated from one of the pregnant females 2 months
postpartum. All samples exhibited a single band on SDS-polyacrylamide
gel electrophoresis at about 90 kDa (data not shown). Peptide mapping
by FAB-MS confirmed the presence of the THP polypeptide (data not
shown). Putative O-glycans were released by reductive
elimination, permethylated, and purified on a Sep-Pak cartridge that
was eluted with a stepwise gradient of aqueous acetonitrile. The
permethylated glycans, which were recovered in the 35 and 50%
acetonitrile fractions, were analyzed by FAB-MS and linkage analysis.
Under the conditions used for reductive elimination, a portion of the
N-glycans is also released. Their presence was taken into
account in the interpretation of the FAB and linkage data.
Analysis of Glycans Released from Male THP by Reductive
Elimination--
FAB-MS analyses of the 35% acetonitrile fractions
from male THP showed several low molecular weight O-glycans,
the most abundant of which (m/z 895 and 1256) were present
in all three samples (Fig. 1 and Table
I). These masses correspond to
compositions NeuAcHexHexNAcitol and
NeuAc2HexHexNAcitol, respectively, and are
consistent with sialylated and desialylated T-antigen
structures (NeuAc Analysis of Glycans Released from Female THP by Reductive
Elimination--
Fig. 2 and Table I show
FAB data obtained from the analysis of THP from a single female. Data
from a further two females are also shown in Table I. Comparison
with the male data allows the following conclusions to be drawn.
(i) The two major glycans observed in the male
(NeuAc1,2HexHexNAcitol) are also found in female THP, but
their abundance varies significantly between individuals and is
generally lower in females than males. (ii) Like the male, the
non-pregnant female appears to contain relatively simple
O-glycans containing no more than six sugar residues. (iii)
In two of the samples analyzed, an abundant signal at m/z
1157 was detected corresponding to FucHex2HexNAcHexNAcitol.
One of these two samples also exhibited a minor signal corresponding to
the presence of a second fucose residue (m/z 1331). These
glycans probably contain Lewisx/a structures
(Gal Uromodulin Contains O-Glycans Not Present in THP--
Fig.
3a and Table
II show FAB data obtained from the
analysis of the 50% Sep-Pak fraction of permethylated glycans from
uromodulin obtained from a single pregnant female. Data from a second
pregnant female are also shown in Table II. The data show striking
differences when compared with THP. The most notable feature is the
presence of major molecular ions corresponding to large
O-glycans rich in fucose and sialic acid which are
completely absent in the THP samples. The most abundant of
these components are observed at m/z 1519 (NeuAcFucHex2HexNAcHexNAcitol), m/z 1880 (NeuAc2FucHex2HexNAcHexNAcitol), and
m/z 2504 (NeuAc2Fuc2Hex3HexNAc2HexNAcitol).
Weaker signals are present at higher mass that correspond to larger
O-glycans carrying additional fucosyl and sialyl residues up
to a composition of
NeuAc3Fuc3Hex4HexNAc3HexNAcitol
(m/z 3487). The abundant signal at m/z 999 (NeuAcHexHexNAcFuc+) is consistent with the presence of
either sialyl Lewisx or sialyl Lewisa. The
majority of the putative Lewis epitopes are sialylated since a signal
at m/z 638 (not shown), representing
FucHexHexNAc+, is minor compared with m/z 999. No signals were detected for fragment ions corresponding to lactosamine
repeats, indicating that the higher mass structures are most likely
produced by branching of O-glycans rather than chain
elongation.
Modification of O-Glycan Profile following
Parturition--
Analysis of THP/uromodulin isolated from the
first pregnant female 2 months after birth of a male baby showed a
dramatic change in the O-glycan profile (Fig.
3b). Notably the sialylated and fucosylated
O-glycans observed in uromodulin had virtually disappeared (for example, compare m/z 1519, 1880, and 2504 in Fig. 3,
a and b), whereas the profile of small
O-glycans that eluted in the 35% Sep-Pak fraction was
largely unaffected and was similar to the non-pregnant state (Fig.
4, a and b).
Confirmation of the Presence of Fucose in Uromodulin
O-Glycans--
Reductively eliminated glycans from uromodulin were
subjected to hydrofluoric acid defucosylation, and the products of the reaction were permethylated and analyzed by FAB-MS after Sep-Pak purification. The data show that the signals attributed to fucose containing O-glycans (Table II) have either disappeared or
are considerably reduced in intensity (compare Fig.
5, a and b). New signals are present (Fig. 5b) consistent with loss of fucose
from the original structures such as m/z 1344 (loss of
fucose from m/z 1519) and m/z 1706 (loss of
fucose from m/z 1880). The fragment ion originally present
at m/z 999, representing a possible sialyl Lewis epitope,
has also virtually disappeared. The signal at m/z 825 (NeuAcHexHexNAc+ fragment ion) is more intense than was
originally detected. This product is expected following the
defucosylation of the putative sialyl Lewis epitope.
Desialylation of Uromodulin O-Glycans--
Tryptic glycopeptides
were desialylated using V. cholerae sialidase, and glycans
were released by reductive elimination, permethylated, and analyzed by
FAB-MS. The data showed the loss of signals with compositions
consistent with the presence of sialic acid (compare Fig.
6, a and b). New
signals were observed at the expected desialylated masses. Thus loss of
one and two sialic acids, respectively, from m/z 1519 and
1880 yields m/z 1157, whereas similar losses from m/z 2142 and 2504 yields m/z 1781. The new
signals at m/z 2230 and 2404 represent desialylation of the
higher mass structures shown in Fig. 6a, specifically
m/z 2230 is derived from m/z 2952 and 3313, and
m/z 2404 is derived from m/z 3126 and 3487. The sialyl Lewisx/a fragment ion (m/z 999)
disappeared concomitant with a significant increase in the signal at
m/z 638 (FucHexHexNAc+), consistent with the
loss of sialic acid from this epitope.
Periodate Cleavage Defines Core Types and Antennae Backbones of
Uromodulin O-Glycans--
Mild periodate oxidation cleaves linear
sections of sugar structures if vicinal hydroxyl groups are present.
Thus, with respect to the O-glycans of uromodulin, the
GalNAcitol and any sialic acids are sensitive to this reagent.
Reductively eliminated glycans were subjected to mild periodate
oxidation followed by reduction, permethylation, Sep-Pak clean up, and
FAB-MS analysis. The FAB data for the 35 and 50% Sep-Pak fractions
(Fig. 7, a and b,
respectively, and Table III) showed
molecular ions consistent with periodate cleavage of the GalNAcitol
residue producing two distinct sets of products, one containing the C-1
to C-4 carbons of the GalNAcitol (denoted C-4) attached to the 3-linked
antenna(e), and the other containing the C-5 and C-6 carbons (denoted
C-2) attached to the 6-linked antenna(e). Thus, m/z 719, 1069, 1342, 1587, 1791, 1967, 2065, and 2240 are attributable to
3-linked antennae because their masses are consistent with the presence
of a C-4 moiety at the reducing end (Table III). Similarly,
m/z 562, 736, 835, and 1009 are consistent with 6-linked
antennae (attached to the C-2 moiety). From these data it is evident
that the sialyl Lewisx/a epitope is present on both
3-linked (m/z 1342) and 6-linked (m/z 1009)
antennae, although the significantly larger signal at m/z 1009 compared with m/z 1342 indicates that attachment to
carbon 6 is more common in these smaller structures. The higher mass signals corresponding to 3-linked antennae have compositions consistent with the possible presence of lactosamine repeats. However, the absence
of A-type fragment ions characteristic of polylactosamine sequences in
the spectra of the intact glycans (see, for example Fig. 3a)
suggests that polylactosamine structures are unlikely to be present.
Consequently 3-linked antennae of compositions NeuAcFuc2Hex3HexNAc2-C-4,
NeuAc2FucHex3HexNAc2-C-4, and
NeuAc2Fuc2Hex3HexNAc2-C-4 are likely to be branched. Their compositions are consistent with the
presence of two sialyl Lewisx epitopes.
Linkage Analysis of Reductively Eliminated Uromodulin
Glycans--
Linkage analysis data for uromodulin are shown in Table
IV. Notable features of the linkage data
are as follows: (i) 3,6-GalNAcitol is significantly more abundant than
3-GalNAcitol, which is consistent with core 2 type structures being
dominant in pregnant samples and is significantly reduced postpartum;
(ii) the presence of 3,6-Gal supports the periodate data that provided
evidence for the existence of branched structures, and this component
was very minor post-pregnancy in accord with the FAB data showing loss of the high molecular weight O-glycans; (iii) the absence of
detectable levels of 6-Gal indicates that the sialic acids are attached
at the 3-position of galactose; this was confirmed by linkage analysis performed after V. cholerae desialylation that showed a loss
of 3-linked galactose and an increase of terminal galactose; (iv) the
presence of 3,4-GlcNAc, which disappears after HF defucosylation without the concomitant appearance of 3-linked GlcNAc, confirms that
sialyl Lewisx and not sialyl Lewisa is present
in the O-glycans; (v) the terminal GalNAc is supportive of
the possible presence of the Sda antigen in a minority of
glycans; (vi) the variously linked mannoses are derived from the
"contaminating" N-glycans.
Structures of the High Molecular Weight O-Glycans in
Uromodulin--
Taking into consideration the FAB-MS, linkage,
exoglycosidase, periodate, and defucosylation data, we arrive at the
following structural conclusions: (i) uromodulin carries a range of
O-glycans that are not present in THP; (ii) these glycans
are rich in sialyl Lewisx and the majority have the core 2 type (Gal The primary goal of the present study was to determine if any
major changes in the glycosylation of THP occurs during human pregnancy. To carry out this investigation, uromodulin was isolated from human pregnancy urine by the salt precipitation method previously employed to isolate THP from non-pregnant females and males (2). This
consistent approach to the isolation of THP and uromodulin is
important, because uromodulin was originally isolated from human
pregnancy urine by a procedure that included lectin affinity chromatography (11). This distinction is also significant because THP
and uromodulin are often used synonymously in many studies (22). It is
abundantly clear from the present study that uromodulin isolated from
human pregnancy urine represents a discrete set of THP glycoforms that
are different from those expressed in nonpregnant females and males.
The present results provide convincing evidence that both uromodulin
and THP express O-glycans. This observation differs from the
result of a previous study suggesting that THP or uromodulin are devoid
of such sequences (23). One possible explanation for this discrepancy
could be the imprecise methods employed in this previous investigation.
Afonso and co-workers (23) digested THP with Pronase to generate
glycopeptides that were then analyzed on gel filtration columns. It is
very difficult to obtain exact structural definition using such an
approach. Moreover, at the time that their study was performed,
O-glycan expression was often detected by measuring the
amount of GalNAc present in glycopeptide fractions. The expression of
the Sda antigen on the terminal ends of
N-glycans associated with both uromodulin and THP precluded
this monosaccharide analysis of glycopeptides as an indicative method
for detecting O-glycan expression.
The N-linked oligosaccharides associated with THP and
uromodulin have been the focus of numerous structural studies employing definitive biophysical analysis (21, 24-27). There are eight potential
N-linked glycosylation sites, of which seven (Asn-52, Asn-56, Asn-208, Asn-251, Asn-298, Asn-372, and Asn-489) are occupied (27). Biantennary, triantennary, and tetraantennary complex type
glycans constitute most of the N-linked oligosaccharides. High mannose type glycans are attached at only one site (Asn-251), where they represent 67% of the total glycans linked at this position (27). The complex type glycans are terminated with the following antennae attached to core mannosyl residues: Gal Rigorous methods of biophysical analysis have now been used to confirm
that O-glycans are also linked to THP. Both males and non-pregnant females express very simple mono- and desialylated derivatives of core 1 type sequences on THP. By contrast, the O-glycans derived from uromodulin are primarily core 2 O-linked glycans that are further branched on the
This specific association of the sialyl Lewisx sequence
with uromodulin could be particularly significant, especially given the
previously reported immunomodulatory activities of this glycoprotein. The sialyl Lewisx antigen
(NeuAc It is also significant in this context to note that neutrophils have
been shown to interact with both THP and uromodulin in in
vitro assay systems. Neutrophils specifically bind to microtiter plates coated with THP (40). This interaction is
calcium-dependent, requires metabolically active cells, and
is inhibited by soluble THP. However, this binding was also partially
inhibited by the peptide sequence YRGDG, suggesting that
integrin-mediated adhesions could play a role in this interaction (40).
Yu and co-workers(41) reported that THP purified from normal human
pregnancy urine increases phagocytosis, complement receptor expression,
and arachidonic acid metabolism of neutrophils. These investigators
suggested that this glycoprotein could play a significant role in the
defense mechanisms of the urinary tract.
The data presented in this paper provide a new impetus for re-examining
the immunomodulatory effects of THP versus uromodulin. In
particular, the current results suggest a potential structural basis
for the differential activity of uromodulin and THP in the antigen-induced T cell proliferation assay system reported by Muchmore
and colleagues (12) over a decade ago. These investigators relied upon
affinity chromatography on concanavalin A-agarose to isolate
uromodulin, whereas in this study the salt precipitation method was
employed (1). This difference could potentially impact immunological
assays. On the other hand, a very substantial percentage of uromodulin
molecules express biantennary and high mannose type glycans based on
the results of previous structural analyses (21). Such THP glycoforms
would be expected to bind to concanavalin A-agarose (42). Thus
differences between the current and previous preparations of uromodulin
may be minimal.
The present investigation indicates that the O-glycans of
THP change radically during pregnancy. This result infers that the glycosylation of THP could be regulated by specific pregnancy-related hormones. The systemic levels of both the estrogens and progesterone are substantially increased in gravid human females (43, 44). It is
significant in this context to note that human steroid hormone receptors are present in the kidneys (45). In baboons, progesterone receptors are localized to the epithelial cells of the thick ascending limbs of the loop of Henle and the most proximal part of the distal convoluted tubule, the primary site of synthesis of THP in the human
kidney (46). Therefore steroid hormonal stimulation occurring during
pregnancy may specifically induce the expression of specific glycosyltransferases required to synthesize the unusual core 2 type
O-glycans linked to uromodulin. Key enzymes that could be under hormonal regulation include the fucosyltransferase(s) essential for the synthesis of the sialyl Lewisx sequence (47) and
the core 2 GlcNAc transferase essential for converting core 1 to core 2 type O-glycans (48). Other
N-acetylglucosaminyltransferases essential for forming
multivalent sialyl Lewisx structures may also be hormonally
regulated in the epithelial cells that synthesize THP.
Despite extensive investigation, the precise physiological role(s) of
THP and uromodulin have not yet been determined (22). However, the
pregnancy-specific expression of differential THP glycoforms suggests a
potential functional role during this process. In a previous study, we
demonstrated that gender-specific changes in the glycosylation of
glycodelin, a glycoprotein synthesized in both the male and female
reproductive tract, led to completely different biological activities
(49, 50). It is our current operating hypothesis that glycosylation
plays a pivotal role in tailoring the function of a subset of
glycoproteins to their gender-specific roles in reproduction.
Structural and functional studies are under way to determine if
THP/uromodulin is yet another glycoprotein that fits into this category.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
S-bridged cysteine residues
as described previously (19) with three modifications. First, the
reduction was performed under a nitrogen atmosphere; second, the
iodoacetic acid incubation was performed under a nitrogen atmosphere at
37 °C; and third, the reaction was terminated and desalted by
dialysis against 4 × 2.5 liters of 50 mM ammonium
bicarbonate, pH 8.5, at 4 °C for 2 days, the dialysate being changed
every 12 h. After dialysis the sample was lyophilized.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2-3Gal
1-3GalNAc and
NeuAc
2-3Gal
1-3(NeuAc
2-6)GalNAc). These simple core 1 type
glycans are found in many glycoproteins including glycophorin,
erythropoietin, and plasminogen. There is some variation between
individuals with respect to the relative abundance of the above two
glycans and the compositions of minor structures present (Table I). For
example, m/z 1140 (NeuAcHexHexNAcHexNAcitol) was detected in
only two samples. This glycan probably carries the Sda
antigen (GalNAc
1-4(NeuAc
2-3)Gal
1-)which is known to be
present on the antennae of THP N-glycans (21). The 50%
acetonitrile fractions showed molecular ions attributable to high
mannose N-glycans (Fig. 1b and Table I). These
are readily identifiable because of their unique compositions and
because they exhibit pairs of molecular ions separated by 16 mass units
due to the incomplete reduction that is characteristic of
N-glycans released under reductive elimination conditions.
O-Glycans, in contrast, are fully reduced under the
conditions employed in our experiments. No significant signals
corresponding to O-glycans were observed in the 50%
fraction.

View larger version (21K):
[in a new window]
Fig. 1.
FAB mass spectra of the reductively
eliminated glycans of THP/uromodulin isolated from a single male.
Glycans were permethylated and subjected to Sep-Pak clean-up.
a, 35% acetonitrile fraction; b, 50%
acetonitrile fraction. Signals are assigned in Table I. The A-type
fragment ion at m/z 1070 is most likely derived from
contaminating N-glycans (see text) that are known to be rich
in the Sda sequence (21).
Assignments of molecular ([M + Na]+) and A-type fragment
ions detected in the FAB-mass spectra of permethylated glycans derived
from three male (M1-M3) and three female (F1-F3) THP samples
1-4/3(Fuc
1-3/4)GlcNAc
1), evidence for which is
provided by a fragment ion at m/z 638 (A-type fragment ion of composition FucHexHexNAc+).

View larger version (25K):
[in a new window]
Fig. 2.
FAB mass spectra of the reductively
eliminated glycans of THP/uromodulin isolated from a single
female. Glycans were permethylated and subjected to Sep-Pak
clean-up. a, 35% acetonitrile fraction; b, 50%
acetonitrile fraction. The signals at m/z 873 and 1234 represent the protonated form of m/z 895 and 1256, respectively. The signals at m/z 897, 947, 1242, and 1258 are contaminants.

View larger version (25K):
[in a new window]
Fig. 3.
FAB mass spectra of the reductively
eliminated glycans of THP/uromodulin isolated from a single pregnant
female. Glycans were permethylated and subjected to Sep-Pak
clean-up. a, 50% acetonitrile fraction during pregnancy;
b, 50% acetonitrile fraction 2 months post-partum. The
minor signals near m/z 2600 and 3300 in b
correspond to N-glycans as exemplified by the presence of
twin peaks separated by 16 mass units.
Assignments of the molecular ([M + Na]+) and A-type
fragment ions detected in the FAB-mass spectra of permethylated glycans
derived from uromodulin

View larger version (19K):
[in a new window]
Fig. 4.
FAB mass spectra of the reductively
eliminated glycans of THP/uromodulin isolated from a single pregnant
female following permethylation and Sep-Pak clean-up.
a, 35% acetonitrile fraction during pregnancy;
b, 35% acetonitrile fraction 2 months after pregnancy. The
signals at m/z 901 and 973 in a are
contaminants.

View larger version (24K):
[in a new window]
Fig. 5.
FAB-mass spectra of the reductively
eliminated glycans of THP/uromodulin isolated from a single pregnant
female before and after treatment with hydrogen fluoride. Both
samples were permethylated and cleaned up by Sep-Pak. a,
50% acetonitrile fraction prior to treatment; b, 50%
acetonitrile fraction following treatment. The signals at
m/z 901, 1105, 1211, and 1309 are contaminants.

View larger version (24K):
[in a new window]
Fig. 6.
FAB-mass spectra of the reductively
eliminated glycans of uromodulin upon treatment of glycopeptides with
Arthrobacter ureafaciens sialidase. Following the
reaction the glycans were released from the glycopeptides by reductive
elimination, permethylated, and purified by Sep-Pak. a,
uromodulin glycans prior to treatment with sialidase; b,
uromodulin glycans after treatment with sialidase. The signals at
m/z 697, 901, 1105, 1211, 1309, 1513, 1718, and 1922 are
contaminants.

View larger version (26K):
[in a new window]
Fig. 7.
FAB-mass spectra of the reductively
eliminated glycans from uromodulin following treatment with
periodate. After periodate treatment the glycans were reduced,
permethylated, and purified by Sep-Pak. a, 35% acetonitrile
fraction; b, 50% acetonitrile fraction. The majority of
signals are assigned in Table III. Signals at m/z 1552, 1757, and 1961 correspond to reduced high mannose glycans
(Man5 to Man7, respectively) whose terminal
GlcNAcitol has been cleaved between carbons 5 and 6 by the periodate
treatment. The signal at m/z 1800 corresponds to residual
Man6GlcNAcGlcNAcitol.
Assignments of molecular ions ([M + Na]+) of reductively
eliminated uromodulin O-glycans following periodate treatment,
reduction, and permethylation
Data from linkage analysis of the partially methylated alditol acetates
obtained from reductively eliminated glycans of uromodulin
1-3(GlcNAc
1-6)GalNAc), in contrast with THP which is
mostly core 1 type; (iii) the periodate data suggest that the 6-linked
antenna has four possible sequences viz. Gal-GlcNAc,
NeuAc-Gal-GlcNAc, Lewisx, and sialyl Lewisx; in
contrast the 3-linked antennae show significantly greater heterogeneity
with at least eight structures being observed; (iv) the largest glycan
observed is a tetradecamer whose composition (NeuAc3Fuc3Hex4HexNAc4)
is consistent with the presence of three sialyl Lewisx
moieties. Structures taking account of these conclusions are summarized
in Fig. 8.

View larger version (17K):
[in a new window]
Fig. 8.
Proposed structures of the unusual
O-glycans present on uromodulin. Linkage analysis
indicates that the branched Gal is substituted at positions 3 and
6.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1-4GlcNAc,
NeuAc
2-3Gal
1-4GlcNAc, NeuAc
2-6Gal
1-4GlcNAc,
Gal3S
1-4GlcNAc, and GalNAc4S
1-4GlcNAc (21). Polylactosamine
type sequences are also attached to some of the N-glycans
associated with THP (28). However, this expression is a donor-specific
feature not found on all samples of this glycoprotein (25).
1-3-linked Gal to generate sophisticated structures expressing up
to three sialyl Lewisx sequences (Fig. 8). Analysis of
maternal THP 2 months postpartum indicates that the synthesis of these
unusual core 2 type O-glycans is strictly
pregnancy-related.
2-3Gal
1-4[Fuc
1-3]GlcNAc) was originally identified as a differentiation antigen associated with neutrophils and monocytes (29, 30). Several groups (31-35) demonstrated that oligosaccharides and glycolipids terminated with the sialyl Lewisx sequence
serve as ligands for E-, P-, and L-selectin-mediated binding. However,
only E-selectin displays preferential adhesion to the sialyl
Lewisx sequence under physiological circumstances.
P-selectin binding to its primary glycoprotein ligand (PSGL-1) requires
the co-presentation of the sialyl Lewisx sequence and a
specific tyrosine sulfate residue on an NH2-terminal mucin-like domain (36, 37). L-selectin forms a tighter interaction with
sulfated forms of the sialyl Lewisx sequence (38). It is
noteworthy that most of the E- and L-selectin ligands on the surface of
murine neutrophils are carried on core 2 O-glycans, based on
results obtained with core 2 GlcNAc transferase knockout mice (39).
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful for the help of Dr. Francis Bowe and Cian O'Gaora. We appreciate the assistance of Drs. Frank Lattanzio and Gerald Pepe for reviewing the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by the Biotechnology and Biological Sciences Research Council and the Wellcome Trust Grants 030825 and 046294 (to A. D. and H. R. M.) and the National Institutes of Health Grants HD35652 (to G. F. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence may be addressed. Tel.: 001-757-446-5650; Fax: 001-757-624-2270; E-mail: gfc@borg.evms.edu.
To whom correspondence may be addressed. Tel.:
44-020-7594-5219; Fax: 44-020-7225-0458; E-mail:
h.morris@ic.ac.uk.
** To whom correspondence may be addressed. Tel.: 44-020-7594-5219; Fax: 44-020-7225-0458; E-mail: a.dell@ic.ac. uk.
Published, JBC Papers in Press, April 18, 2000 DOI 10.1074/jbc.M001534200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: THP, Tamm-Horsfall glycoprotein; FAB-MS, fast atom bombardment-mass spectrometry; IL, interleukin.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Tamm, I., and Horsfall, F. L. (1952) J. Exp. Med. 95, 71-97 |
| 2. | Tamm, I., and Horsfall, F. L. (1950) Proc. Soc. Exp. Biol. Med. 74, 108-114 |
| 3. | Orskov, I., Ferencz, A., and Orskov, F. (1980) Lancet 1, 887 |
| 4. | Orskov, I., Orskov, F., and Birch-Andersen, A. (1980) Infect. Immun. 27, 657-666 |
| 5. | Mattey, M., and Naftalin, L. (1992) Experientia (Basel) 48, 975-980 |
| 6. | Hoyer, J. R., and Seiler, M. W. (1979) Kidney Int. 16, 279-289 |
| 7. | Adcock, E. W. D., Teasdale, T., August, C. S., Cox, S., Meschia, G., Ballaglia, T. C., and Naughton, M. A. (1973) Science 181, 845-847 |
| 8. | Contractor, S. F., and Davies, H. (1973) Nat. New Biol. 243, 284-286 |
| 9. | Muchmore, A. V., and Blaese, R. M. (1977) J. Immunol. 118, 881-886 |
| 10. | Caldwell, J. L., Stites, D. P., and Fudenberg, H. H. (1975) J. Immunol. 115, 1249-1253 |
| 11. | Muchmore, A. V., and Decker, J. M. (1985) Science 229, 479-481 |
| 12. | Hession, C., Decker, J. M., Sherblom, A. P., Kumar, S., Yue, C. C., Mattaliano, R. J., Tizard, R., Kawashima, E., Schmeissner, U., Heletky, S., Chow, E. P., Burne, C. A., Shaw, A., and Muchmore, A. V. (1987) Science 237, 1479-1484 |
| 13. | Pennica, D., Kohr, W. J., Kuang, W. J., Glaister, D., Aggarwal, B. B., Chen, E. Y., and Goeddel, D. V. (1987) Science 236, 83-88 |
| 14. | Muchmore, A. V., and Decker, J. M. (1987) J. Immunol. 138, 2541-2546 |
| 15. | Sherblom, A. P., Decker, J. M., and Muchmore, A. V. (1988) J. Biol. Chem. 263, 5418-5424 |
| 16. | Sherblom, A. P., Sathyamoorthy, N., Decker, J. M., and Muchmore, A. V. (1989) J. Immunol 143, 939-944 |
| 17. | Moonen, P., Gaffner, R., and Wingfield, P. (1988) FEBS Lett. 226, 314-318 |
| 18. | Tandai-Hiruma, M., Endo, T., and Kobata, A. (1999) J. Biol. Chem. 274, 4459-4466 |
| 19. | Dell, A., Khoo, K.-H., Panico, M., McDowell, R. A., Etienne, A. T., Reason, A. J., and Morris, H. R. (1993) in in Glycobiology: A Practical Approach (Fukuda, M. , and Kobata, A., eds) , pp. 187-222, Oxford University Press, Oxford |
| 20. | Albersheim, P., Nevins, D. J., English, P. D., and Karr, A. (1967) Carbohydr. Res. 5, 340-345 |
| 21. | Hard, K., Van Zadelhoff, G., Moonen, P., Kamerling, J. P., and Vliegenthart, F. G. (1992) Eur. J. Biochem. 209, 895-915 |
| 22. | Kumar, S. (1998) Eur. J. Clin. Invest. 28, 483-484 |
| 23. | Afonso, A.-M. M., Charlwood, P. A., and Marshall, R. D. (1981) Carbohydr. Res. 89, 309-319 |
| 24. | Smagula, R. M., Van Halbeek, H., Decker, J. M., Muchmore, A. V., Moody, C. E., and Sherblom, A. P. (1990) Glycoconj. J. 7, 609-624 |
| 25. | Van Rooijen, J. J., Kamerling, J. P., and Vliegenthart, J. F. (1998) Glycobiology 8, 1065-1075 |
| 26. | Van Rooijen, J. J., Kamerling, J. P., and Vliegenthart, J. F. (1998) Eur. J. Biochem. 256, 471-487 |
| 27. | Van Rooijen, J. J., Voskamp, A. F., Kamerling, J. P., and Vliegenthart, J. F. (1999) Glycobiology 9, 21-30 |
| 28. | Donald, A. S., Yates, A. D., Soh, C. P., Morgan, W. T., and Watkins, W. M. (1983) Biochem. Biophys. Res. Commun. 115, 625-631 |
| 29. | Fukuda, M., Spooncer, E., Oates, J. E., Dell, A., and Klock, J. C. (1984) J. Biol. Chem. 259, 10925-10935 |
| 30. | Mizoguchi, A., Takasaki, S., Maeda, S., and Kobata, A. (1984) J. Biol. Chem. 259, 11949-11957 |
| 31. | Lowe, J. B., Stoolman, L. M., Nair, R. P., Larsen, R. D., Berhend, T. L., and Marks, R. M. (1990) Cell 63, 475-484 |
| 32. | Phillips, M. L., Nudelman, E., Gaeta, F. C., Perez, M., Singhal, A. K., Hakomori, S., and Paulson, J. C. (1990) Science 250, 1130-1132 |
| 33. | Tiemeyer, M., Swiedler, S. J., Ishihara, M., Moreland, M., Schweingruber, H., Hirtzer, P., and Brandley, B. K. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 1138-1142 |
| 34. | Polley, M. J., Phillips, M. L., Wayner, E., Nudelman, E., Singhal, A. K., Hakomori, S., and Paulson, J. C. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6224-6228 |
| 35. | Foxall, C., Watson, S. R., Dowbenko, D., Fennie, C., Lasky, L. A., Kiso, M., Hasegawa, A., Asa, D., and Brandley, B. K. (1992) J. Cell Biol. 117, 895-902 |
| 36. | Pouyani, T., and Seed, B. (1995) Cell 83, 333-343 |
| 37. | Wilkins, P. P., Moore, K. L., McEver, R. P., and Cummings, R. D. (1995) J. Biol. Chem. 270, 22677-22680 |
| 38. | Imai, Y., Lasky, L. A., and Rosen, S. D. (1993) Nature 361, 555-557 |
| 39. | Ellies, L. G., Tsuboi, S., Petryniak, B., Lowe, J. B., Fukuda, M., and Marth, J. D. (1998) Immunity 9, 881-890 |
| 40. | Toma, G., Bates, J. M., Jr., and Kumar, S. (1994) Biochem. Biophys. Res. Commun. 200, 275-282 |
| 41. | Yu, C. L., Lin, W. M., Liao, T. S., Tsai, C. Y., Sun, K. H., and Chen, K. H. (1992) Immunopharmacology 24, 181-190 |
| 42. | Cummings, R. D., and Kornfeld, S. (1982) J. Biol. Chem. 257, 11235-11240 |
| 43. | Tulchinsky, D., Hobel, C. J., Yeager, E., and Marshall, J. R. (1972) Am. J. Obstet. Gynecol. 112, 1095-1100 |
| 44. | Tulchinsky, D., and Hobel, C. J. (1973) Am. J. Obstet. Gynecol. 117, 884-893 |
| 45. | Concolino, G., Marocchi, A., Concolino, F., Sciarra, F., Di Silverio, F., and Conti, C. (1976) J. Steroid Biochem. 7, 831-835 |
| 46. | Weaker, F. J., Herbert, D. C., and Sheridan, P. J. (1984) J. Urol. 132, 792-794 |
| 47. | Maly, P., Thall, A., Petryniak, B., Rogers, C. E., Smith, P. L., Marks, R. M., Kelly, R. J., Gersten, K. M., Cheng, G., Saunders, T. L., Camper, S. A., Camphausen, R. T., Sullivan, F. X., Isogai, Y., Hindsgaul, O., von Andrian, U. H., and Lowe, J. B. (1996) Cell 86, 643-653 |
| 48. | Bierhuizen, M. F., and Fukuda, M. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9326-9330 |
| 49. | Dell, A., Morris, H. R., Easton, R. L., Panico, M., Patankar, M., Oehniger, S., Koistinen, R., Koistinen, H., Seppala, M., and Clark, G. F. (1995) J. Biol. Chem. 270, 24116-24126 |
| 50. | Morris, H. R., Dell, A., Easton, R. L., Panico, M., Koistinen, H., Koistinen, R., Oehninger, S., Patankar, M. S., Seppala, M., and Clark, G. F. (1996) J. Biol. Chem. 271, 32159-32167 |
This article has been cited by other articles:
![]() |
K. Klisch, E. Jeanrond, P.-C. Pang, A. Pich, G. Schuler, V. Dantzer, M. P Kowalewski, and A. Dell A Tetraantennary Glycan with Bisecting N-Acetylglucosamine and the Sda Antigen is the Predominant N-Glycan on Bovine Pregnancy-Associated Glycoproteins Glycobiology, January 1, 2008; 18(1): 42 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matousovic, J. Novak, T. Yanagihara, M. Tomana, Z. Moldoveanu, R. Kulhavy, B. A. Julian, K. Konecny, and J. Mestecky IgA-containing immune complexes in the urine of IgA nephropathy patients Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2478 - 2484. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Rohfritsch, M. Rinnbauer, J. F.G. Vliegenthart, and J. P. Kamerling Donor specificity in the glycosylation of Tamm-Horsfall glycoprotein: Conservation of the Sda determinant in pairs of twins Glycobiology, April 1, 2004; 14(4): 365 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kui Wong, R. L. Easton, M. Panico, M. Sutton-Smith, J. C. Morrison, F. A. Lattanzio, H. R. Morris, G. F. Clark, A. Dell, and M. S. Patankar Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125 J. Biol. Chem., August 1, 2003; 278(31): 28619 - 28634. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Menozzi, A.-S. Debrie, J.-P. Tissier, C. Locht, K. Pethe, and D. Raze Interaction of human Tamm-Horsfall glycoprotein with Bordetella pertussis toxin Microbiology, April 1, 2002; 148(4): 1193 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhu, J. Cheng, J. Gao, H. Lepor, Z.-T. Zhang, J. Pak, and X.-R. Wu Isolation of mouse THP gene promoter and demonstration of its kidney-specific activity in transgenic mice Am J Physiol Renal Physiol, April 1, 2002; 282(4): F608 - F617. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dell and H. R. Morris Glycoprotein Structure Determination by Mass Spectrometry Science, March 23, 2001; 291(5512): 2351 - 2356. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||